STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Aura Biosciences (NASDAQ: AURA) will participate in the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025. CEO Elisabet de los Pinos, PhD, will appear in a fireside chat at 10:50 a.m. ET. A live webcast will be available on the company’s Investors & Media Events & Presentations page and a replay will be archived for 90 days following the presentation.

This presentation provides an investor update opportunity with company leadership and a public webcast for remote access.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 10:50 a.m. ET.

The live webcast of the fireside chat will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at https://ir.aurabiosciences.com/events-and-presentations, where a replay of the webcast will be archived for 90 days following the presentation date.

About Aura Biosciences

Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for early choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Our mission is to grow as an innovative global oncology company that positively transforms the lives of patients.

For more information, visit aurabiosciences.com. Follow us on X (formerly Twitter) @AuraBiosciences and visit us on LinkedIn.

Investor and Media Relations Contact:
Alex Dasalla
Head of Investor Relations and Corporate Communications
IR@aurabiosciences.com


FAQ

When will Aura Biosciences (AURA) present at the Evercore Healthcare Conference?

Aura will present on Tuesday, December 2, 2025 at 10:50 a.m. ET.

Who from Aura Biosciences (AURA) will speak at the Evercore Healthcare Conference?

Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the fireside chat.

How can investors watch Aura Biosciences (AURA) at the Evercore Healthcare Conference?

A live webcast will be available on the company’s Investors & Media > Events & Presentations page.

Will there be a replay of the Aura Biosciences (AURA) webcast and for how long?

Yes. A replay will be archived on the events page for 90 days after the presentation.

Where is the Aura Biosciences (AURA) webcast hosted?

The webcast is hosted on the company’s investor website under Events & Presentations.

Is the Aura Biosciences (AURA) Evercore presentation available to the public?

Yes. The fireside chat will be webcast live and accessible via the investor website.
Aura Biosciences, Inc.

NASDAQ:AURA

AURA Rankings

AURA Latest News

AURA Latest SEC Filings

AURA Stock Data

345.46M
57.16M
1.98%
84.55%
4.5%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON